Next Article in Journal
Caffeic Acid Phenethyl Ester (CAPE) Synergistically Enhances Paclitaxel Activity in Ovarian Cancer Cells
Next Article in Special Issue
Biological Activity of Genus Hypericum Sect. Hypericum Species—H. tetrapterum, H. maculatum subsp. immaculatum, H. triquetrifolium
Previous Article in Journal
Volatile Profile of Strawberry Fruits and Influence of Different Drying Methods on Their Aroma and Flavor: A Review
Previous Article in Special Issue
Quantitative HPLC–UV Study of Lignans in Anthriscus sylvestris
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 15
10.3390/molecules28155812
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion

by
Amr M. Shehabeldine
1,*,
Ahmed S. Doghish
2,3,*,
Walaa A. El-Dakroury
4,
Mahmoud M. H. Hassanin
5,
Abdulaziz A. Al-Askar
6,
Hamada AbdElgawad
7 and
Amr H. Hashem
1,*
1
Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City 11884, Egypt
2
Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City 11829, Egypt
3
Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City 11231, Egypt
4
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City 11829, Egypt
5
Ornamental, Medicinal and Aromatic Plant Disease Department, Plant Pathology Research Institute, Agricultural Research Center (ARC), Giza 12619, Egypt
6
Department of Botany and Microbiology, Faculty of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
7
Integrated Molecular Plant Physiology Research (IMPRES), Department of Biology, University of Antwerp, 2022 Antwerp, Belgium
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(15), 5812; https://doi.org/10.3390/molecules28155812
Submission received: 19 June 2023 / Revised: 17 July 2023 / Accepted: 26 July 2023 / Published: 1 August 2023
(This article belongs to the Special Issue Bioactive Compounds from Plants with Pharmaceutical Interest II)
Browse Figures
Versions Notes

Abstract

:
In the current study, clove oil nanoemulsion (CL-nanoemulsion) and emulsion (CL-emulsion) were prepared through an ecofriendly method. The prepared CL-nanoemulsion and CL-emulsion were characterized using dynamic light scattering (DLS) and a transmission electron microscope (TEM), where results illustrated that CL-nanoemulsion droplets were approximately 32.67 nm in size and spherical in shape, while CL-nanoemulsion droplets were approximately 225.8 nm with a spherical shape. The antibacterial activity of CL-nanoemulsion and CL-emulsion was carried out using a microbroth dilution method. Results revealed that the preferred CL-nanoemulsion had minimal MIC values between 0.31 and 5 mg/mL. The antibiofilm efficacy of CL-nanoemulsion against S. aureus significantly decreased the development of biofilm compared with CL-emulsion. Furthermore, results illustrated that CL-nanoemulsion showed antifungal activity significantly higher than CL-emulsion. Moreover, the prepared CL-nanoemulsion exhibited outstanding antifungal efficiency toward Candida albicans, Cryptococcus neoformans, Aspergillus brasiliensis, A. flavus, and A. fumigatus where MICs were 12.5, 3.12, 0.78, 1.56, and 1.56 mg/mL, respectively. Additionally, the prepared CL-nanoemulsion was analyzed for its antineoplastic effects through a modified MTT assay for evaluating apoptotic and cytotoxic effects using HepG2 and MCF-7 cell lines. MCF-7 breast cancer cells showed the lowest IC50 values (3.4-fold) in CL-nanoemulsion relative to that of CL-emulsion. Thus, CL-nanoemulsion induces apoptosis in breast cancer cells by inducing caspase-8 and -9 activity and suppressing VEGFR-2. In conclusion, the prepared CL-nanoemulsion had antibacterial, antifungal, and antibiofilm as well as anticancer properties, which can be used in different biomedical applications after extensive studies in vivo.

1. Introduction

Multidrug-resistant (MDR) bacteria are more common, which highlights a rising concern about appropriate therapies for diseases brought on by these infections [1]. Humans exposed to bacteria that are highly and/or multidrug-resistant have experienced significant cases of illness and mortality due to the absence of appropriate treatments [2]. As a result, microbial resistance is an important issue for the community, and there is a need to research and identify novel chemicals with antimicrobial activities that have no adverse effects on the host body.
Nanotechnology has a wide range of applications across various fields such as medicine, agriculture, electronics, energy, remediation, and water treatment [3,4,5,6,7,8,9,10]. Essential oil nanoemulsion is a type of nanotechnology-based delivery system that allows for the efficient encapsulation and delivery of essential oils. Nanoemulsions are stable, transparent, and homogeneous mixtures of oil, water, and emulsifiers, with droplet sizes typically ranging from 10 to 200 nm [11]. Nanoemulsion enhances the surface area of essential oil by lowering the droplet size, making it easier for the body to absorb and consume [12]. Essential oil nanoemulsion has several possibilities in the food, cosmetics, and medical sectors. They increase flavor and nutritional value in lotions, creams, sprays, and food products [13,14,15,16]. Antimicrobial activity has been observed in essential oil nanoemulsion against a broad spectrum of microorganisms, including bacteria, fungi, and viruses [17,18]. This antimicrobial activity is due to the presence of bioactive compounds in essential oils, which can disrupt the cell membrane of microorganisms and inhibit their growth [19].
Clove is also known as the expanding buds of Syzygium aromaticum (L.). Syzygium is the biggest class in the Myrtaceae family, with over 1200–1800 blooming plant varieties [20]. Steam distillation, cold pressing, or supercritical CO2 extraction and solvent extraction are methods for obtaining clove essential oils, which are exceptionally concentrated herbal extracts. [21]. Steam distillation is a technique used to separate volatile compounds from nonvolatile substances, typically employed in the extraction of essential oils from plants. Steam distillation is carried out by passing dry steam through the plant material whereby the steam volatile compounds are volatilized, condensed, and collected in receivers [22]. Also, the extraction of oil using supercritical CO2 is a popular method in the extraction of oils due to its efficiency, selectivity, and environmentally friendly nature [23]. Supercritical CO2 refers to a state of CO2 where it is above its critical temperature (31.1 °C) and critical pressure (73.8 bar) [24]. In this state, CO2 exhibits unique properties that make it useful in the extraction of oils. Clove essential oil contains over 30 distinct substances, of which eugenol makes up at least 50%, and the other 10–40% is composed of eugenyl acetate, humulene, and caryophyllene [25]. Clove essential oil has been used to heal burns and wounds, as well as anesthesia in dentistry. Furthermore, its usage in many commercial uses has been described, and it is widely employed in fragrances, detergents, and as a washing medium in histology work. Multiple investigations have found that aromatic plants such as clove, thyme, and mint have antibacterial, antiviral, anticarcinogenic, and antifungal properties. However, due to its significant antibacterial and antioxidant properties, clove has earned a lot of popularity among various spices [26]. The advantages associated with plant compounds have been known since time immemorial. However, their advantages are becoming more well understood, owing to their diverse medicinal characteristics [27]. The antibacterial capacity of clove oil nanoemulsion has been discovered to be significantly greater than that of conventional preparation [28].
Since nanotechnology has proven to be an effective technique for treating cancer, researchers have concentrated their efforts on treating a variety of cancers. The effects of CL-nanoemulsion on apoptosis in both breast (MCF-7) and liver (HepG2) cancer cells were evaluated. These promising results suggest that a natural product, CL-nanoemulsion, may hold the key to facilitating the development of cancer treatments, notably for breast cancer. This work aims to prepare CL-nanoemulsion through an ecofriendly method and to characterize it using TEM and DLS, as well as to assess its antibacterial, antibiofilm, antifungal, and anticancer potentialities.

2. Results and Discussion

2.1. Preparation and Characterization of CL-Nanoemulsion

Clove oil was extracted from Syzygium aromaticum using the ecofriendly method. To convert clove oil to emulsion or nanoemulsion, an emulsifying agent must be used through an emulsification process [29]. Emulsification is a process that involves the mixing and stabilization of two immiscible liquids, typically oil and water, to form a stable emulsion. An emulsion is a mixture of tiny droplets of one liquid dispersed in another liquid. Emulsions can be either oil-in-water (O/W) or water-in-oil (W/O), depending on the continuous phase [30]. Thus, in the current study, Tween 80 was used as an emulsifying agent in emulsion and nanoemulsion formation from clove oil. Tween 80 is widely used for the formation of emulsions due to Tween having a high hydrophilic–lipophilic balance (HLB) value, which supports the creation of oil-in-water emulsions [31]. The result revealed that changing color to white indicates the formation of emulsion or nanoemulsion according to the method used. To confirm the formation of CL-nanoemulsion, dynamic light scattering and TEM analyses were carried out.

2.2. Dynamic Light Scattering

Figure 1 shows the stable CL-nanoemulsion prepared by the ultrasonication method for 40 min at 350 W after 40 days of storage at room temperature. Previous studies confirmed that surfactant concentrations affected significantly the hydrodynamic diameter and polydispersity of nanoemulsions [32,33]. Results revealed that CL-nanoemulsion droplets were approximately 32.67 nm in size; the polydispersity index (PDI) for particles was 0.355, as shown in Figure 1B. On the other hand, CL-emulsion droplets were approximately 225.8 nm in size; the PDI for particles was 0.242, as illustrated in Figure 1A. Dai et al. [34] reported that nanoemulsion has a small droplet size in the presence of double bonds in the nonpolar chain of non-ionic surfactants. Hashem, Abdelaziz, Hassanin, Al-Askar, AbdElgawad, and Attia [18] succeeded in the preparation of CL-nanoemulsion where mean droplets were 91.3 nm and PDI was 0.448. The mean hydrodynamic diameter rose in direct proportion to the quantity of additional clove essential oil because of an increase in the internal capacity of the nanoparticles covered by the oil. This may also be a result of changes in the organic viscosity and physicochemical properties of solvents released into water. Krishnamoorthy et al. [35] prepared cleome viscosa oil nanoemulsion and noticed the dimensions of droplets NE retention at ambient temperature varied significantly, ranging from 10 to 19 nm, 23 to 24 nm, and 163 to 63 nm for 1:3, 1:2, and 1:1 (oil: surfactant (v/v)), respectively. Enayatifard et al. [36] illustrated that oregano nanoemulsion exhibited low PDI (0.11), and the mean droplet was 72.26 nm.

2.3. Transmission Electron Microscopy (TEM)

The actual dimensions and shape of the CL-nanoemulsion drops are revealed by TEM analysis. The TEM micrograph showed that the CL-nanoemulsion was spherical in shape. CL-nanoemulsion droplets were in the range of 27.7–52 nm (Figure 2B). CL-emulsion was also spherical in shape. CL-emulsion droplets were in the range of 242.9–428.6 nm (Figure 2A). The obtained results were in agreement with Hashem, Abdelaziz, Hassanin, Al-Askar, AbdElgawad, and Attia [18], who found that TEM micrograph CL-nanoemulsion was spherical in shape and droplet size was in the range of 36.4–57.1 nm. Hammad and Hasanin [37] reported that the shape of spearmint and thyme nanoemulsions was spherical with mono- or di-dispersed; also, the size was in the ranges (5.91–9.77) and (25.4–32.9), respectively. Abd-Elsalam and Khokhlov [38] illustrated that TEM results of eugenol oil nanoemulsion appeared spherical and the size was in the range of 50–110 nm.

2.4. Determination of MIC and MBC

CL-emulsion and CL-nanoemulsion have good antibacterial activity against both Gram-positive and Gram-negative bacteria, according to extensive research in the literature [39]. The preliminary detection of CL-emulsion and CL-nanoemulsion against tested bacteria was carried out using a microbroth double dilution assay. Using a resazurin-mediated microtiter plate test, a visual evaluation of the inhibitory impact of the test compounds was done using the color shift of the resazurin indicator [40]. MIC of the CL-emulsion against B. cereus, S. aureus, E. coli, and K. oxytoca was 1.25, 2.5, 10, and 5 mg/mL, respectively, while MIC of the clove oil nanoemulsion against B. cereus, S. aureus, E. coli, and K. oxytoca was 0.31, 0.62, 1.25, and 5 mg/mL, respectively. Our results showed that clove oil nanoemulsion possesses the lowest MIC ranging from 0.31 to 5 mg/mL (Table 1). The MBC is the lowest quantity of CL-nanoemulsion necessary to totally eliminate the bacteria under certain circumstances (no development on the agar dish) [2,41]. MBC of the clove oil nanoemulsion against B. cereus, S. aureus, E. coli, and K. oxytoca were 0.62, 1.25, 2.5, and 10 mg/mL, respectively, whereas the MBC of the CL-emulsion was 2.5, 5, 20, and 10 mg/mL, respectively. One of the previous studies by Sharma [42] reported that Gram-negative bacteria such as E. coli were shown to be more vulnerable to CL-nanoemulsion than Gram-positive bacteria; this is in agreement with our results. One probable reason is that the walls of their cells differ in content depending on whether they are Gram-positive or Gram-negative. E. coli has a distinctive cell membrane with a periplasmic gap that renders it more susceptible to antimicrobial effects [43]. Also, the improvement in CL-emulsion bioavailability within the nanoemulsion leads to homogeneous oil dispersion and discharge that is adequate to suppress bacterial growth.

2.5. Antibiofilm Activity of CL-Emulsion and CL-Nanoemulsion

Biofilm suppression was determined with a conventional crystal violet technique. At 0.5 × MIC and 0.25 × MIC, the antibiofilm efficacy of CL-emulsion and CL-nanoemulsion against S. aureus decreased the development of biofilm by 10.3 and 9.4% and 52 and 36.5%, respectively. Bacterial biofilm inhibition of CL-emulsion and CL-nanoemulsion showed considerable biofilm-inhibiting action against S. aureus (p < 0.05) (Figure 3). This medication had the strongest inhibitory capacity for biofilm formation against S. aureus at tested sub-MIC dosages without hindering planktonic development. The granularity of CL-nanoemulsions constitutes one of the key factors in their influence on biofilm inhibition action since tiny particles have a greater surface area for contact with microbes [44,45]. The presence of the S. aureus biofilm generated on the coverslip glass was visualized using CLSM. The microscopy image was obtained 48 h following the CL-nanoemulsion treatment at 0.5 MIC. Qualitative assessment to confirm biofilm inhibition was generated using Live/Dead labeling in CLSM (Figure 4). The untreated biofilm had numerous live adhering cells that had been well incorporated into the biofilm (Figure 4A). Biofilm treated with CL-nanoemulsion at 0.5, 0.25, and 0.06 MIC showed a small number of dead cells among the population (Figure 4B–D). Biofilm treated with CL-emulsion at 0.5, 0.25, and 0.06 MIC showed a small number of dead cells among the population (Figure 4E–G). When produced in the absence of the CL-nanoemulsion, dense biofilm forms with a tight topology characterized by a big cluster shape, and uniformly dispersed fluorescent green colors of active cells can be readily seen in the control biofilm. In contrast, the alleged CL-nanoemulsion might be an effective instrument for disrupting the biofilm and preventing its adhesion to the outer layer of the coverslips while also preventing the evolution of S. aureus. This finding matched up with our investigations on crystal violet biofilm inhibition. The susceptibility of mature biofilm toward CL-nanoemulsion was also seen with a substantial decrease (p < 0.01) in bacterial counts in biofilms treated in comparison to control biofilm. Our results agree with Chaieb et al. [46], who showed that P. aeruginosa strain creation of biofilm resulted in biofilm breakdown, with biofilm losing its rigidity entirely in the absence of living cells. This demonstrates the excellent effectiveness of levofloxacin loaded with CL-nanoemulsion in the elimination of preformed biofilms.

2.6. Antifungal Activity

Antifungal activity of CL-emulsion and CL-nanoemulsion was assessed against C. albicans, C. neoformans, A. brasiliensis, A. flavus, and A. fumigatus, where both MIC and MFC were determined as shown in Table 2. Results revealed that CL-nanoemulsion exhibited antifungal activity higher than CL-emulsion toward all selected fungal strains. Moreover, MICs of CL-nanoemulsion were 12.5, 3.12, 0.78, 1.56, and 1.56 mg/mL against C. albicans, C. neoformans, A. brasiliensis, A. flavus, and A. fumigatus, respectively. Also, MFCs of CL-nanoemulsion were 12.5, 6.25, 3.12, 1.56, and 6.25 mg/mL, respectively. These findings demonstrate the potential of CL-nanoemulsion against all investigated fungus strains, where the most sensitive strains were A. brasiliensis and A. flavus, but C. albicans was the least sensitive strain, among others. On the other hand, CL-emulsion showed weak antifungal activity toward all investigated fungal strains, where MICs were 50, 25, 6.25, 6.25, and 12.5 mg/mL against C. albicans, C. neoformans, A. brasiliensis, A. flavus, and A. fumigatus, respectively. Moreover, MFCs were 100, 25, 25, 12.5, and 50 mg/mL, respectively. Alghaith et al. [47] found that CL-nanoemulsion has antifungal activity toward the dermatophyte fungus Trichophyton rubrum. Another study reported that CL-nanoemulsion has promising antifungal activity against A. niger ATCC 1015 and C. albicans ATCC 3153 in which the impediment areas were 2.13 and 3.19 mm, respectively. Antifungal activity of CL-nanoemulsion may be attributed to the presence of eugenol, which can disrupt fungal cell membranes or inhibit germination and sporulation of the fungus. Also, it may be attributed to CL-nanoemulsion having the ability to inhibit ergosterol synthesis, inhibit enzymes of cell wall synthesis, altering of the morphology of the cell wall, and produce ROS [48].

2.7. Cytotoxic Effect of CL-Emulsion and CL-Nanoemulsion

Nanoemulsions are employed as drug carriers to deliver medicines and phytochemicals to cells in an efficient way. They enhance the biological effects of their ingredients, including their antibacterial, antioxidant, and anticancer capabilities. The use of nanoemulsions as secure, biocompatible, and effective drug delivery devices has significantly changed cancer treatment plans and demonstrated a high level of safety [49]. Numerous research has used thyme, eucalyptus, cinnamon, and clove oil essential oils as therapeutic nanoemulsions [50]. In the current study, essential CL-oil (dissolved in DMSO), CL-emulsion, and CL-nanoemulsion were tested for their cytotoxic effects on HepG2 liver cancer cells and MCF-7 breast cancer cells, respectively. The most potent cytotoxic effect was seen in MCF-7 cells, as shown by the lowest IC50 values (Figure 5). Treatment with CL-nanoemulsion produced the lowest IC50 value of 12.93 ± 0.49 µg/mL. Additionally, treatment with CL-emulsion resulted in IC50 values of 43.36 ± 1.63 µg/mL, while the IC50 for Taxol was 8.90 ± 0.73 µg/mL.

2.8. Effect of CL-Emulsion and CL-Nanoemulsion on CASP8 and CASP9 Activities

In Figure 6, we see how CL-emulsion and CL-nanoemulsion affect the apoptotic markers CASP8 and -9. Treatment of MCF-7 cells with CL-emulsion substantially boosted CASP8 and CASP9 activity (0.523 ± 0.037 ng/mL and 16.9 ± 0.38 pg/mL, respectively) compared to the control (0.257 ± 0.061 ng/mL and 2.714 ± 0.19 pg/mL, respectively). In addition, compared to CL-emulsion treatments, CASP8 and -9 activities were shown to be greatest after being exposed to CL-nanoemulsion (0.811 ± 0.049 ng/mL and 21.63 ± 0.42 pg/mL, respectively). Apoptosis activates DNA fragmentation enzymes through CASP8 and -9 activations [51]. These compounds caused MCF-7 cells to undergo apoptosis via CASP8 and -9 activations.

2.9. Effect of CL-Emulsion and CL-Nanoemulsion on VEGFR-2

Figure 7 shows that the levels of VEGFR-2 were dramatically reduced by CL-emulsion and CL-nanoemulsion compared to the control (1.793 ± 0.036 ng/mL).
When comparing CL-emulsion (0.748 ± 0.016 ng/mL) to CL-nanoemulsion (0.499 ± 0.017 ng/mL), VEGFR-2 levels were found to be much lower in the latter. Overactivation of VEGFR-2 is known to drive angiogenesis that promotes solid tumor development, which corroborated the findings of Falcon et al. For many cancers, including breast cancer, blocking the VEGFR-2 pathway has emerged as an essential therapeutic strategy [52,53,54].
The dependability of cellular proliferation and development can be attributed to the role of apoptosis pathways, which are impaired in cancer cells. These cancer cells inhibit apoptotic pathways, leading to a reduction in apoptotic gene expressions and ultimately preventing apoptotic death. Caspases 8 and 9 are recognized as the effectors of the apoptosis response, and their primary function is to facilitate the induction of the tumor cells’ death. The apoptotic effect on breast cancer cells has been found to be upregulated by the cytotoxic properties of several plant essential oils, including Syzygium aromaticum (clove) [55]. Clove is noted for its significant antioxidant properties attributed to its constituent compounds such as tannins, flavonoids, glycosides, and volatile phenolic oils such as eugenol and acetyl eugenol. The phytochemical ingredients present in cloves exhibit potent antioxidant, antiproliferative, antimicrobial, disinfectant, and anti-inflammatory properties, thereby rendering them suitable agents for cancer chemoprevention [56]. The efficacy of this compound can be further enhanced by using a nanoemulsion formulation. Nanoemulsions have garnered significant attention from scientists in the pharmaceutical industry and in the discipline of cancer treatment due to their capacity to enhance the solubility and efficacy of therapeutic agents, including tetanus toxoid, insulin, and anticancer agents, during drug delivery [57].
In addition, it is noteworthy that plant-derived bioactive substances, such as phenolic and flavonoids, exhibit therapeutic potential but possess limited solubility in polar solvents. Consequently, the efficacy of plant-based anticancer substances is hindered by their inadequate solubility and gastrointestinal absorption. The enhancement of solubility and gastrointestinal uptake of plant bioactive substances can be achieved by incorporating them into a suitable carrier, including nanoemulsions. This approach can effectively address the aforementioned issue. The utilization of nanoemulsions in drug delivery can be advantageous due to the enhanced solubility of the therapeutic agent, the prolonged half-life, and the potential to surmount the resistance of cancerous cells toward chemotherapy [58].

3. Material and Methods

3.1. Chemicals and Reagents

Taxol (paclitaxel) was bought from Sigma Chemical in St. Louis, MO. Sigma Aldrich (Sigma, St. Louis, MO, USA) supplied the 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and the dimethyl sulfoxide (DMSO). From Gibco (Gibco, TFS frpm PPA, Pasching, Austria) we obtained fetal bovine serum (FBS), phosphate buffer saline (PBS), Dulbecco’s modified Eagle’s medium (DMEM), penicillin/streptomycin (Pen/Strep) solution, and trypsin-EDTA. Phosphotungstic acid, ethanol 95%, SYTO 9, propidium iodide (PI), Tween 80, and resazurin dye were purchased from Sigma Aldrich, Sparks, NV, USA.

3.2. Preparation of CL-Nanoemulsion and CL-Emulsion

The steam distillation method was used for the extraction of clove essential oil according to the method used by [59]. Dried and ground clove flower buds (50 g) were put in a steam flask. The steam distillation lasted 6 h. The recovered condensate was distilled again using n-hexane as the solvent. By evaporating the n-hexane, clove oil was produced. To prepare CL-nanoemulsion, 5 mL of Tween 80 was added slowly to 20 mL of CL with gentle stirring for 40 min, and then completed to 100 mL with distilled water. The mixture was sonicated using an ultrasonicator for 40 min at 350 W. The essential oil emulsion was made in the manner described above but without the use of a sonicator.

3.3. Measurement of CL-Nanoemulsion Droplet Size

At room temperature, the Zeta Nano ZS (Malvern Instruments, UK) was used to measure the size of the CL-nanoemulsion droplets using a dynamic light scattering analysis. Before testing, 30 µL of CL-nanoemulsion was diluted with 3 mL of water at 25 °C. The mean of the Z-average of three separate batches of the CL-nanoemulsion was used to express particle size information. We examined the CL-nanoemulsion’s droplet size and polydisparity index (PDI).

3.4. Transmission Electron Microscopy (TEM)

On a film-coated 200-mesh copper specimen grid, 20 µL of sample was placed. Then, one drop of 3% phosphotungstic acid was used to stain the grid and allowed to dry for 3 min. Using a TEM microscope (Tecnai G20, Super twin, double tilt, FEI, The Netherlands) set to 200 kV, the coated grid was analyzed [60]. TEM of CL-nanoemulsion was carried out at RCMB, Al-Azhar University, while TEM of CL-emulsion was carried out at the Agricultural Research Center (ARC), Egypt.

4. Antibacterial Activity

4.1. Microorganisms

Bacillus cereus ATTC 11778, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 35218, and Klebsiella oxytoca ATCC 51983 were selected for antibacterial screening, while Staphylococcus aureus (MSSA) ATCC-25923 was used as positive controls of biofilm production.

4.2. MIC Determination by Resazurin Dye Method

Microbroth dilution method by resazurin dye method was applied for the determination of antimicrobial activities [61]. First, 100 µL of bacterial suspension was added to the nutrient broth and cultured for 24 h at 37 ± 2 °C to test the antibacterial effectiveness [62,63,64,65]. Microdilutions of overnight established culture strains were grown in Luria-Bertani broth in 96-well plates (McFarland turbidity of 0.5). CL-emulsion and CL-nanoemulsion at various concentrations (20, 10, 5, 2.5,1.25, 0.62, 0.31, 0.15, and 0.07%) were added [66]. The lowest concentration of chemicals tested at which the dye colour changed. The minimum bactericidal concentration (MBC) was determined when no colonies formed on the agar plate.

4.3. Evaluation of Antibiofilm Activity

The effect of CL-emulsion and CL-nanoemulsion on Staphylococcus aureus (MSSA) ATCC-25923 biofilm development was determined by the crystal violet staining technique [67,68]. Six levels lowered from 0.5 × MIC of CL-emulsion and CL-nanoemulsion were added to 96-well plates as previously described. For 48 h, the liquid combination was eliminated, and the wells were stained for 15 min with 0.1 mL 0.4% crystal violet after being cleaned twice with sterile water. Following that, the dye attached to the biofilm was dissolved using 95% ethanol. The plates were read at 492 nm in an ELISA reader, and all tests were done in triplicate [46,69]:

4.4. Observation of Biofilm Reduction by Confocal Laser Scanning Microscopy (CLSM)

At 0.5 MIC, one-milliliter cell suspensions of Staphylococcus aureus ATCC 25923 were distributed onto microtiter plate wells containing CL-emulsion and CL-nanoemulsion. Following incubation, the coverslips were carefully rinsed with 0.01 M buffered saline to carefully eliminate non-adhered bacteria and were stained with 500 µL of a combined dye solution of SYTO 9 and propidium iodide (PI) [44]. Following that, visualization was carried out using a ZEISS LSM laser scanning microscope with a 40 oil-immersion lens with settings for the green signal of 488 nm and the red signal of 461 nm and long-pass emission filters of 500–550 nm and 590–650 nm, respectively [70].

4.5. Antifungal Activity

Antifungal activity of CL-emulsion and CL-nanoemulsion was assessed against Candida albicans ATCC 90028, Cryptococcus neoformans ATCC 14116, Aspergillus brasiliensis ATCC 16404, A. flavus RCMB 02782, and A. fumigatus ATCC 204305. The MIC and MFC of the CL-emulsion and CL-nanoemulsion were analyzed using the broth microdilution method [71]. The microdilution broth method was applied for detecting the MIC of all tested fungal stains. Briefly, in a microplate, 10 µL of each fungal strain was added to Sabouraud Dextrose broth amended with different concentrations of CL-emulsion and CL-nanoemulsion (100–0.19 mg/mL), and then incubated at 30 °C for 48 h. For detection of MIC for unicellular fungi, 20 µL of resazurin dye was added. A visual assessment was done from blue to pink dye inside viable cells. On the other hand, MIC for filamentous fungi was detected by examining growth visually without adding dye [7,8,72]. To detect minimum fungicidal concentration (MFC), 100 µL was transferred from a well that had no visible growth to Sabouraud Dextrose plates and then incubated at 30 °C for 48 h.

5. Anticancer Activity

5.1. Cell Lines

Cell lines for both breast (MCF-7) and liver (HepG2) cancers were obtained from ATCC (Manassas, VA, USA) and grown in DMEM (Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS) and 1% pen/strep solution (TFS Inc., City of Fairfax, VA, USA) at 37 °C (with 5% carbon dioxide).

5.2. Cell Viability Assay

The MTT assay was used to quantify cytotoxic activity [73]. In 96-well plates, the cells were planted at a density of 1.2 × 104 cells/well and given 24 h to grow. After 24 h, the media with the various essential CL-oil (dissolved in DMSO), CL-emulsion, and CL-nanoemulsion concentrations were changed. After 48 h, the MTT test was carried out by adding 100 μL (5 mg/mL of MTT in PBS) followed by 4 h of incubation at 37 °C in the wells. Each well had 100 μL of DMSO added to it to dissolve the formazan crystals. Ten minutes were spent incubating the plates at 37 °C. Microplate reader readings at 570 nm were used to calculate optical densities [74].

5.3. Assessment of Caspase-8 (CASP8) and Caspase-9 (CASP9) Activities and VEGFR-2

ELISA kits from DRG International Inc. (Springfield, NJ, USA) were used to test CASP8 (human, EIA-4863) and CASP9 (human, EIA-4860). VEGFR-2 was measured using an ELISA kit (Catalogue #: OKAG02083) (AVIVA system biology, San Diego, CA, USA) per manufacturer instructions.

5.4. Statistical Analysis

GraphPad Prism 8.0 examined all findings. Means ± SD were reported for at least three separate experiments (n = 3). ANOVA and Tukey’s multiple comparisons tests examined all groups’ significant differences. p < 0.05 was significant.

6. Conclusions

In the current study, CL-nanoemulsion and CL-emulsion were successfully prepared using an ecofriendly method. Also, CL-nanoemulsion and CL-emulsion were characterized using DLS and TEM. Results confirmed that the prepared CL-nanoemulsion was in nano form with a spherical shape. Results revealed that CL-nanoemulsion exhibited outstanding antibacterial activity compared with CL-emulsion, where CL-nanoemulsion possesses the lowest MIC ranging from 0.31 to 5 mg/mL toward pathogenic Gram-negative and Gram-positive bacteria. Moreover, the antibiofilm efficacy of CL-nanoemulsion against S. aureus has significantly decreased the development of biofilm compared with CL-emulsion. Furthermore, CL-nanoemulsion displayed promising antifungal action against both unicellular and multicellular fungi. Also, the anticancer impact of CL-nanoemulsion is due to the induction of apoptosis in MCF-7 breast cancer cells by increasing caspase-8 and -9 activity and decreasing VEGFR-2 compared with CL-emulsion.

Author Contributions

Conceptualization, A.M.S. and A.H.H.; Methodology, A.M.S., A.S.D., H.A. and A.H.H.; Software, M.M.H.H., H.A. and A.H.H.; Validation, A.M.S. and A.S.D.; Formal analysis, A.M.S., W.A.E.-D., H.A. and A.H.H.; Investigation, A.M.S., A.S.D., M.M.H.H. and A.H.H.; Resources, M.M.H.H.; Data curation, A.M.S., W.A.E.-D. and A.A.A.-A.; Writing—original draft, A.M.S., A.S.D., W.A.E.-D., M.M.H.H., A.A.A.-A., H.A. and A.H.H.; Writing—review & editing, A.S.D., W.A.E.-D., M.M.H.H., A.A.A.-A., H.A. and A.H.H.; Project administration, A.A.A.-A.; Funding acquisition, A.A.A.-A. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by King Saud University, Riyadh, Saudi Arabia, project number (RSP2023R505).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data and materials are viable.

Acknowledgments

The authors would like to thank the Botany and Microbiology Department, Faculty of Science, Al-Azhar University as well as the Faculty of Pharmacy, Badr University. Moreover, the authors extend their appreciation to the researcher supporting project number (RSP2023R505), King Saud University, Riyadh, Saudi Arabia, for funding this work.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Meade, E.; Slattery, M.A.; Garvey, M. Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: Resistance is futile? Antibiotics 2020, 9, 32. [Google Scholar] [CrossRef] [Green Version]
  2. Okba, M.M.; Baki, P.M.A.; Abu-Elghait, M.; Shehabeldine, A.M.; El-Sherei, M.M.; Khaleel, A.E.; Salem, M.A. UPLC-ESI-MS/MS profiling of the underground parts of common Iris species in relation to their anti-virulence activities against Staphylococcus aureus. J. Ethnopharmacol. 2022, 282, 114658. [Google Scholar] [CrossRef] [PubMed]
  3. Hashem, A.H.; Al Abboud, M.A.; Alawlaqi, M.M.; Abdelghany, T.M.; Hasanin, M. Synthesis of Nanocapsules Based on Biosynthesized Nickel Nanoparticles and Potato Starch: Antimicrobial, Antioxidant, and Anticancer Activity. Starch-Stärke 2022, 74, 2100165. [Google Scholar] [CrossRef]
  4. Hashem, A.H.; Shehabeldine, A.M.; Ali, O.M.; Salem, S.S. Synthesis of Chitosan-Based Gold Nanoparticles: Antimicrobial and Wound-Healing Activities. Polymers 2022, 14, 2293. [Google Scholar] [CrossRef] [PubMed]
  5. Hashem, A.H.; Hasanin, M.; Kamel, S.; Dacrory, S. A new approach for antimicrobial and antiviral activities of biocompatible nanocomposite based on cellulose, amino acid and graphene oxide. Colloids Surf. B Biointerfaces 2022, 209, 112172. [Google Scholar] [CrossRef] [PubMed]
  6. Hasanin, M.; Hashem, A.H.; El-Rashedy, A.A.; Kamel, S. Synthesis of novel heterocyclic compounds based on dialdehyde cellulose: Characterization, antimicrobial, antitumor activity, molecular dynamics simulation and target identification. Cellulose 2021, 28, 8355–8374. [Google Scholar] [CrossRef]
  7. Ali, O.M.; Hasanin, M.S.; Suleiman, W.B.; Helal, E.E.-H.; Hashem, A.H. Green biosynthesis of titanium dioxide quantum dots using watermelon peel waste: Antimicrobial, antioxidant, and anticancer activities. Biomass Convers. Biorefinery 2022. [Google Scholar] [CrossRef]
  8. Saied, E.; Salem, S.S.; Al-Askar, A.A.; Elkady, F.M.; Arishi, A.A.; Hashem, A.H. Mycosynthesis of Hematite (α-Fe2O3) Nanoparticles Using Aspergillus niger and Their Antimicrobial and Photocatalytic Activities. Bioengineering 2022, 9, 397. [Google Scholar] [CrossRef]
  9. Saied, E.; Hashem, A.H.; Ali, O.M.; Selim, S.; Almuhayawi, M.S.; Elbahnasawy, M.A. Photocatalytic and Antimicrobial Activities of Biosynthesized Silver Nanoparticles Using Cytobacillus firmus. Life 2022, 12, 1331. [Google Scholar] [CrossRef]
  10. Albalawi, M.A.; Abdelaziz, A.M.; Attia, M.S.; Saied, E.; Elganzory, H.H.; Hashem, A.H. Mycosynthesis of Silica Nanoparticles Using Aspergillus niger: Control of Alternaria solani Causing Early Blight Disease, Induction of Innate Immunity and Reducing of Oxidative Stress in Eggplant. Antioxidants 2022, 11, 2323. [Google Scholar] [CrossRef]
  11. da Silva, B.D.; do Rosário, D.K.A.; Weitz, D.A.; Conte-Junior, C.A. Essential oil nanoemulsions: Properties, development, and application in meat and meat products. Trends Food Sci. Technol. 2022, 121, 1–13. [Google Scholar] [CrossRef]
  12. Maurya, A.; Singh, V.K.; Das, S.; Prasad, J.; Kedia, A.; Upadhyay, N.; Dubey, N.K.; Dwivedy, A.K. Essential Oil Nanoemulsion as Eco-Friendly and Safe Preservative: Bioefficacy Against Microbial Food Deterioration and Toxin Secretion, Mode of Action, and Future Opportunities. Front. Microbiol. 2021, 12, 751062. [Google Scholar] [CrossRef] [PubMed]
  13. Mushtaq, A.; Mohd Wani, S.; Malik, A.R.; Gull, A.; Ramniwas, S.; Ahmad Nayik, G.; Ercisli, S.; Alina Marc, R.; Ullah, R.; Bari, A. Recent insights into Nanoemulsions: Their preparation, properties and applications. Food Chem. X 2023, 18, 100684. [Google Scholar] [CrossRef]
  14. Aswathanarayan, J.B.; Vittal, R.R. Nanoemulsions and their potential applications in food industry. Front. Sustain. Food Syst. 2019, 3, 95. [Google Scholar] [CrossRef] [Green Version]
  15. Ashaolu, T.J. Nanoemulsions for health, food, and cosmetics: A review. Environ. Chem. Lett. 2021, 19, 3381–3395. [Google Scholar] [CrossRef]
  16. Atanase, L.-I.; Larraya, C.; Tranchant, J.-F.; Save, M. Rational design of tetrahydrogeraniol-based hydrophobically modified poly(acrylic acid) as emulsifier of terpene-in-water transparent nanoemulsions. Eur. Polym. J. 2017, 94, 248–258. [Google Scholar] [CrossRef]
  17. Guidotti-Takeuchi, M.; de Morais Ribeiro, L.N.; dos Santos, F.A.L.; Rossi, D.A.; Lucia, F.D.; de Melo, R.T. Essential Oil-Based Nanoparticles as Antimicrobial Agents in the Food Industry. Microorganisms 2022, 10, 1504. [Google Scholar] [CrossRef] [PubMed]
  18. Hashem, A.H.; Abdelaziz, A.M.; Hassanin, M.M.; Al-Askar, A.A.; AbdElgawad, H.; Attia, M.S. Potential Impacts of Clove Essential Oil Nanoemulsion as Bio Fungicides against Neoscytalidium Blight Disease of Carum carvi L. Agronomy 2023, 13, 1114. [Google Scholar] [CrossRef]
  19. Chouhan, S.; Sharma, K.; Guleria, S. Antimicrobial Activity of Some Essential Oils-Present Status and Future Perspectives. Medicines 2017, 4, 58. [Google Scholar] [CrossRef] [Green Version]
  20. Idowu, S.; Adekoya, A.E.; Igiehon, O.O.; Idowu, A.T. Clove (Syzygium aromaticum) spices: A review on their bioactivities, current use, and potential application in dairy products. J. Food Meas. Charact. 2021, 15, 3419–3435. [Google Scholar] [CrossRef]
  21. Aziz, Z.A.A.; Ahmad, A.; Setapar, S.H.M.; Karakucuk, A.; Azim, M.M.; Lokhat, D.; Rafatullah, M.; Ganash, M.; Kamal, M.A.; Ashraf, G.M. Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential—A Review. Curr. Drug Metab. 2018, 19, 1100–1110. [Google Scholar] [CrossRef]
  22. Pushpangadan, P.; George, V. Basil. In Handbook of Herbs and Spices; Elsevier: Amsterdam, The Netherlands, 2012; pp. 55–72. [Google Scholar]
  23. Picot-Allain, C.; Mahomoodally, M.F.; Ak, G.; Zengin, G. Conventional versus green extraction techniques—A comparative perspective. Curr. Opin. Food Sci. 2021, 40, 144–156. [Google Scholar] [CrossRef]
  24. Uwineza, P.A.; Waśkiewicz, A. Recent advances in supercritical fluid extraction of natural bioactive compounds from natural plant materials. Molecules 2020, 25, 3847. [Google Scholar] [CrossRef]
  25. Kumar Pandey, V.; Shams, R.; Singh, R.; Dar, A.H.; Pandiselvam, R.; Rusu, A.V.; Trif, M. A comprehensive review on clove (Caryophyllus aromaticus L.) essential oil and its significance in the formulation of edible coatings for potential food applications. Front. Nutr. 2022, 9, 987674. [Google Scholar] [CrossRef] [PubMed]
  26. Sarkic, A.; Stappen, I. Essential oils and their single compounds in cosmetics—A critical review. Cosmetics 2018, 5, 11. [Google Scholar] [CrossRef] [Green Version]
  27. Beyene, B.; Beyene, B.; Deribe, H. Review on application and management of medicinal plants for the livelihood of the local community. J. Resour. Dev. Manag. 2016, 22, 33–39. [Google Scholar]
  28. Sun, H.; Luo, D.; Zheng, S.; Li, Z.; Xu, W. Antimicrobial behavior and mechanism of clove oil nanoemulsion. J. Food Sci. Technol. 2022, 59, 1939–1947. [Google Scholar] [CrossRef]
  29. Shahavi, M.H.; Hosseini, M.; Jahanshahi, M.; Meyer, R.L.; Darzi, G.N. Evaluation of critical parameters for preparation of stable clove oil nanoemulsion. Arab. J. Chem. 2019, 12, 3225–3230. [Google Scholar] [CrossRef] [Green Version]
  30. Umar, A.A.; Saaid, I.B.M.; Sulaimon, A.A.; Pilus, R.B.M. A review of petroleum emulsions and recent progress on water-in-crude oil emulsions stabilized by natural surfactants and solids. J. Pet. Sci. Eng. 2018, 165, 673–690. [Google Scholar] [CrossRef]
  31. Lian, H.; Peng, Y.; Shi, J.; Wang, Q. Effect of emulsifier hydrophilic-lipophilic balance (HLB) on the release of thyme essential oil from chitosan films. Food Hydrocoll. 2019, 97, 105213. [Google Scholar] [CrossRef]
  32. Silva, H.D.; Cerqueira, M.A.; Vicente, A.A. Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions. J. Food Eng. 2015, 167, 89–98. [Google Scholar] [CrossRef] [Green Version]
  33. Sarheed, O.; Dibi, M.; Ramesh, K. Studies on the Effect of Oil and Surfactant on the Formation of Alginate-Based O/W Lidocaine Nanocarriers Using Nanoemulsion Template. Pharmaceutics 2020, 12, 1223. [Google Scholar] [CrossRef] [PubMed]
  34. Dai, L.; Li, W.; Hou, X. Effect of the molecular structure of mixed nonionic surfactants on the temperature of miniemulsion formation. Colloids Surf. A Physicochem. Eng. Asp. 1997, 125, 27–32. [Google Scholar] [CrossRef]
  35. Krishnamoorthy, R.; Gassem, M.A.; Athinarayanan, J.; Periyasamy, V.S.; Prasad, S.; Alshatwi, A.A. Antifungal activity of nanoemulsion from Cleome viscosa essential oil against food-borne pathogenic Candida albicans. Saudi J. Biol. Sci. 2021, 28, 286–293. [Google Scholar] [CrossRef]
  36. Enayatifard, R.; Akbari, J.; Babaei, A.; Rostamkalaei, S.S.; Hashemi, S.M.H.; Habibi, E. Anti-microbial potential of nano-emulsion form of essential oil obtained from aerial parts of Origanum vulgare L. as Food Additive. Adv. Pharm. Bull. 2021, 11, 327. [Google Scholar] [CrossRef]
  37. Hammad, E.A.; Hasanin, M.M.H. Antagonistic Effect of Nanoemulsions of Some Essential Oils against Fusarium oxysporum and Root-Knot Nematode Meloidogyne javanica on Coleus Plants. Pak. J. Nematol. 2022, 40, 35–48. [Google Scholar] [CrossRef]
  38. Abd-Elsalam, K.A.; Khokhlov, A.R. Eugenol oil nanoemulsion: Antifungal activity against Fusarium oxysporum f. sp. vasinfectum and phytotoxicity on cottonseeds. Appl. Nanosci. 2015, 5, 255–265. [Google Scholar] [CrossRef] [Green Version]
  39. Mohandoss, S.; Pandimurugan, R.; Lee, Y.R.; Palanisamy, S.; Senthilkumar, M. In situ synthesis and characterization of colloidal AuNPs capped nano-chitosan containing poly (2,5-dimethoxyaniline) nanocomposites for biomedical applications. J. Biomater. Sci. Polym. Ed. 2022, 33, 1083–1101. [Google Scholar] [CrossRef]
  40. Khare, T.; Mahalunkar, S.; Shriram, V.; Gosavi, S.; Kumar, V. Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli. Environ. Res. 2021, 199, 111321. [Google Scholar] [CrossRef]
  41. Zangeneh, M.M.; Saneei, S.; Zangeneh, A.; Toushmalani, R.; Haddadi, A.; Almasi, M.; Amiri-Paryan, A. Preparation, characterization, and evaluation of cytotoxicity, antioxidant, cutaneous wound healing, antibacterial, and antifungal effects of gold nanoparticles using the aqueous extract of Falcaria vulgaris leaves. Appl. Organomet. Chem. 2019, 33, e5216. [Google Scholar] [CrossRef]
  42. Sharma, M.; Mann, B.; Pothuraju, R.; Sharma, R.; Kumar, R. Physico-chemical characterization of ultrasound assisted clove oil-loaded nanoemulsion: As enhanced antimicrobial potential. Biotechnol. Rep. 2022, 34, e00720. [Google Scholar] [CrossRef]
  43. Duffy, C.F.; Power, R.F. Antioxidant and antimicrobial properties of some Chinese plant extracts. Int. J. Antimicrob. Agents 2001, 17, 527–530. [Google Scholar] [CrossRef] [PubMed]
  44. Chen, Y.; Liu, T.; Wang, K.; Hou, C.; Cai, S.; Huang, Y.; Du, Z.; Huang, H.; Kong, J.; Chen, Y. Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro. PLoS ONE 2016, 11, e0153468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Gurunathan, S.; Han, J.W.; Kwon, D.-N.; Kim, J.-H. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 2014, 9, 373. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Chaieb, K.; Kouidhi, B.; Jrah, H.; Mahdouani, K.; Bakhrouf, A. Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement. Altern. Med. 2011, 11, 29. [Google Scholar] [CrossRef] [Green Version]
  47. Alghaith, A.F.; Alshehri, S.; Alhakamy, N.A. Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea. Drug Deliv. 2021, 28, 343–356. [Google Scholar] [CrossRef]
  48. Burt, S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food Microbiol. 2004, 94, 223–253. [Google Scholar] [CrossRef]
  49. El-Dakroury, W.A.; Zewail, M.B.; Elsabahy, M.; Shabana, M.E.; Asaad, G.F. Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates exceptional efficiency in amelioration of peptic ulcer. Int. J. Pharm. 2022, 611, 121303. [Google Scholar] [CrossRef]
  50. Khan, I.; Bahuguna, A.; Kumar, P.; Bajpai, V.K.; Kang, S.C. In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis. Sci. Rep. 2018, 8, 144. [Google Scholar] [CrossRef] [Green Version]
  51. Gong, L.; Tang, Y.; An, R.; Lin, M.; Chen, L.; Du, J. RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways. Cell Death Dis. 2017, 8, e3080. [Google Scholar] [CrossRef] [Green Version]
  52. Falcon, B.L.; Chintharlapalli, S.; Uhlik, M.T.; Pytowski, B. Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents. Pharmacol. Ther. 2016, 164, 204–225. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Al-Warhi, T.; Sallam, A.-A.M.; Hemeda, L.R.; El Hassab, M.A.; Aljaeed, N.; Alotaibi, O.J.; Doghish, A.S.; Noshy, M.; Eldehna, W.M.; Ibrahim, M.H. Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals 2022, 15, 1262. [Google Scholar] [CrossRef] [PubMed]
  54. Ismail, A.; Mokhlis, H.A.; Sharaky, M.; Sobhy, M.H.; Hassanein, S.S.; Doghish, A.S.; Salama, S.A.; Mariee, A.D.; Attia, Y.M. Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase. Pathol.-Res. Pract. 2022, 240, 154211. [Google Scholar] [CrossRef] [PubMed]
  55. Sznarkowska, A.; Kostecka, A.; Meller, K.; Bielawski, K.P. Inhibition of cancer antioxidant defense by natural compounds. Oncotarget 2017, 8, 15996. [Google Scholar] [CrossRef] [Green Version]
  56. Batiha, G.E.-S.; Alkazmi, L.M.; Wasef, L.G.; Beshbishy, A.M.; Nadwa, E.H.; Rashwan, E.K. Syzygium aromaticum L. (Myrtaceae): Traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules 2020, 10, 202. [Google Scholar] [CrossRef] [Green Version]
  57. Ahmad, N.; Alam, M.A.; Ahmad, F.J.; Sarafroz, M.; Ansari, K.; Sharma, S.; Amir, M. Ultrasonication techniques used for the preparation of novel Eugenol-Nanoemulsion in the treatment of wounds healings and anti-inflammatory. J. Drug Deliv. Sci. Technol. 2018, 46, 461–473. [Google Scholar] [CrossRef]
  58. Abadi, A.V.M.; Karimi, E.; Oskoueian, E.; Mohammad, G.R.K.S.; Shafaei, N. Chemical investigation and screening of anti-cancer potential of Syzygium aromaticum L. bud (clove) essential oil nanoemulsion. 3 Biotech 2022, 12, 49. [Google Scholar] [CrossRef]
  59. Ratri, P.J.; Ayurini, M.; Khumaini, K.; Rohbiya, A. Clove oil extraction by steam distillation and utilization of clove buds waste as potential candidate for eco-friendly packaging. J. Bahan Alam Terbarukan 2020, 9, 47–54. [Google Scholar] [CrossRef]
  60. Saloko, S.; Darmadji, P.; Setiaji, B.; Pranoto, Y.; Anal, A. Encapsulation of coconut shell liquid smoke in chitosan-maltodextrin based nanoparticles. Int. Food Res. J. 2013, 20, 1269. [Google Scholar]
  61. Balouiri, M.; Sadiki, M.; Ibnsouda, S.K. Methods for in vitro evaluating antimicrobial activity: A review. J. Pharm. Anal. 2016, 6, 71–79. [Google Scholar] [CrossRef] [Green Version]
  62. Elshikh, M.; Ahmed, S.; Funston, S.; Dunlop, P.; McGaw, M.; Marchant, R.; Banat, I.M. Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants. Biotechnol. Lett. 2016, 38, 1015–1019. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Hashem, A.H.; Selim, T.A.; Alruhaili, M.H.; Selim, S.; Alkhalifah, D.H.M.; Al Jaouni, S.K.; Salem, S.S. Unveiling Antimicrobial and Insecticidal Activities of Biosynthesized Selenium Nanoparticles Using Prickly Pear Peel Waste. J. Funct. Biomater. 2022, 13, 112. [Google Scholar] [CrossRef] [PubMed]
  64. El-Naggar, M.E.; Hasanin, M.; Hashem, A.H. Eco-Friendly Synthesis of Superhydrophobic Antimicrobial Film Based on Cellulose Acetate/Polycaprolactone Loaded with the Green Biosynthesized Copper Nanoparticles for Food Packaging Application. J. Polym. Environ. 2022, 30, 1820–1832. [Google Scholar] [CrossRef]
  65. Lashin, I.; Hasanin, M.; Hassan, S.A.M.; Hashem, A.H. Green biosynthesis of zinc and selenium oxide nanoparticles using callus extract of Ziziphus spina-christi: Characterization, antimicrobial, and antioxidant activity. Biomass Convers. Biorefinery 2023, 13, 10133–10146. [Google Scholar] [CrossRef]
  66. Siritongsuk, P.; Hongsing, N.; Thammawithan, S.; Daduang, S.; Klaynongsruang, S.; Tuanyok, A.; Patramanon, R. Two-phase bactericidal mechanism of silver nanoparticles against Burkholderia pseudomallei. PLoS ONE 2016, 11, e0168098. [Google Scholar] [CrossRef]
  67. Rakhmawatie, M.D.; Wibawa, T.; Lisdiyanti, P.; Pratiwi, W.R. Evaluation of crystal violet decolorization assay and resazurin microplate assay for antimycobacterial screening. Heliyon 2019, 5, e02263. [Google Scholar] [CrossRef] [Green Version]
  68. Suganya, S.; Ishwarya, R.; Jayakumar, R.; Govindarajan, M.; Alharbi, N.; Kadaikunnan, S.; Khaled, J.; Al-anbr, M.; Vaseeharan, B. New insecticides and antimicrobials derived from Sargassum wightii and Halimeda gracillis seaweeds: Toxicity against mosquito vectors and antibiofilm activity against microbial pathogens. S. Afr. J. Bot. 2019, 125, 466–480. [Google Scholar] [CrossRef]
  69. Shehabeldine, A.M.; Amin, B.H.; Hagras, F.A.; Ramadan, A.A.; Kamel, M.R.; Ahmed, M.A.; Atia, K.H.; Salem, S.S. Potential antimicrobial and antibiofilm properties of copper oxide nanoparticles: Time-kill kinetic essay and ultrastructure of pathogenic bacterial cells. Appl. Biochem. Biotechnol. 2023, 195, 467–485. [Google Scholar] [CrossRef] [PubMed]
  70. Shehabeldine, A.M.; Salem, S.S.; Ali, O.M.; Abd-Elsalam, K.A.; Elkady, F.M.; Hashem, A.H. Multifunctional silver nanoparticles based on chitosan: Antibacterial, antibiofilm, antifungal, antioxidant, and wound-healing activities. J. Fungi 2022, 8, 612. [Google Scholar] [CrossRef]
  71. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Clin. Lab Stand. Inst. 2016, 35, 16–38. [Google Scholar]
  72. Hashem, A.H.; Shehabeldine, A.M.; Abdelaziz, A.M.; Amin, B.H.; Sharaf, M.H. Antifungal Activity of Endophytic Aspergillus terreus Extract Against Some Fungi Causing Mucormycosis: Ultrastructural Study. Appl. Biochem. Biotechnol. 2022, 194, 3468–3482. [Google Scholar] [CrossRef] [PubMed]
  73. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef] [PubMed]
  74. Okba, M.M.; Ezzat, M.I.; Shehabeldine, A.M.; Ezzat, S.M. Eurycomanol and eurycomanone as potent inducers for cell-cycle arrest and apoptosis in small and large human lung cancer cell lines. Nat. Prod. Res. 2023, 37, 1856–1862. [Google Scholar] [CrossRef] [PubMed]
Molecules 28 05812 g001
Figure 1. DLS of CL-emulsion (A) (peak at 225.8 nm and PDI = 0.242) and CL-nanoemulsion (B) (peak at 32.67 nm and PDI = 0.355).
Figure 1. DLS of CL-emulsion (A) (peak at 225.8 nm and PDI = 0.242) and CL-nanoemulsion (B) (peak at 32.67 nm and PDI = 0.355).
Molecules 28 05812 g001
Molecules 28 05812 g002
Figure 2. Transmission electron microscopic image of CL-emulsion (A) and CL-nanoemulsion (B).
Figure 2. Transmission electron microscopic image of CL-emulsion (A) and CL-nanoemulsion (B).
Molecules 28 05812 g002
Molecules 28 05812 g003
Figure 3. S. aureus biofilm inhibition in the presence of CL-emulsion and CL-nanoemulsion at Sub.MIC.
Figure 3. S. aureus biofilm inhibition in the presence of CL-emulsion and CL-nanoemulsion at Sub.MIC.
Molecules 28 05812 g003
Molecules 28 05812 g004
Figure 4. CLSM analysis of biofilms development by S. aureus without treatment (A) & biofilms development by S. aureus incubated with CL-nanoemulsion at 0.5 MIC, 0.25 MIC, and 0.06 MIC (B–D), respectively, for 24 h. Also, CLSM analysis of biofilms formed by S. aureus incubated with CL-emulsion at 0.5 MIC, 0.25 MIC, and 0.06 MIC (E–G), respectively, for 24 h.
Figure 4. CLSM analysis of biofilms development by S. aureus without treatment (A) & biofilms development by S. aureus incubated with CL-nanoemulsion at 0.5 MIC, 0.25 MIC, and 0.06 MIC (B–D), respectively, for 24 h. Also, CLSM analysis of biofilms formed by S. aureus incubated with CL-emulsion at 0.5 MIC, 0.25 MIC, and 0.06 MIC (E–G), respectively, for 24 h.
Molecules 28 05812 g004
Molecules 28 05812 g005
Figure 5. Cytotoxic effect of Taxol, CL-emulsion, and CL-nanoemulsion toward MCF-7 and HepG2 cell lines. The results are presented as means ± SD from three different tests, with * denoting a significant p value from the Taxol group at p < 0.001, $ denoting a significant p value from the essential CL-oil group at p < 0.001, and # indicating a significant p value from the CL-emulsion group at p < 0.001.
Figure 5. Cytotoxic effect of Taxol, CL-emulsion, and CL-nanoemulsion toward MCF-7 and HepG2 cell lines. The results are presented as means ± SD from three different tests, with * denoting a significant p value from the Taxol group at p < 0.001, $ denoting a significant p value from the essential CL-oil group at p < 0.001, and # indicating a significant p value from the CL-emulsion group at p < 0.001.
Molecules 28 05812 g005
Molecules 28 05812 g006
Figure 6. Effects of Taxol, CL-emulsion, and CL-nanoemulsion on CASP8 and CASP9 ((A,B), respectively) in MCF-7 cells compared to Taxol. The data are shown as mean ± SD from three separate tests, with * indicating a significant p value from the control group at p < 0.001.
Figure 6. Effects of Taxol, CL-emulsion, and CL-nanoemulsion on CASP8 and CASP9 ((A,B), respectively) in MCF-7 cells compared to Taxol. The data are shown as mean ± SD from three separate tests, with * indicating a significant p value from the control group at p < 0.001.
Molecules 28 05812 g006
Molecules 28 05812 g007
Figure 7. Effects of Taxol, CL-emulsion, and CL-nanoemulsion on VEGFR-2 in MCF-7 cells compared to Taxol. Statistics are presented as mean ± SD from three separate tests, with * indicating a significant p value from the control group at p < 0.001.
Figure 7. Effects of Taxol, CL-emulsion, and CL-nanoemulsion on VEGFR-2 in MCF-7 cells compared to Taxol. Statistics are presented as mean ± SD from three separate tests, with * indicating a significant p value from the control group at p < 0.001.
Molecules 28 05812 g007
Table 1. MIC (mg/mL) and MBC (mg/mL) of CL-emulsion and CL-nanoemulsion.
Table 1. MIC (mg/mL) and MBC (mg/mL) of CL-emulsion and CL-nanoemulsion.
B. subtilisS. aureusE. coliK. oxytoca
MIC
(mg/mL)		MBC
(mg/mL)		MICMBCMICMBCMICMBC
CL-emulsion1.252.52.551020510
CL-nanoemulsion0.310.620.621.251.252.5510
Ciprofloxacin0.621.250.621.251.251.250.621.25
Table 2. MIC (mg/mL) and MFC (mg/mL) of CL-emulsion and CL-nanoemulsion toward fungal strains.
Table 2. MIC (mg/mL) and MFC (mg/mL) of CL-emulsion and CL-nanoemulsion toward fungal strains.
Fungal
Strains 		CL-EmulsionCL-NanoemulsionVoriconazole
MIC *MFC MIC MFC MIC MFC
C. albicans5010012.512.52550
C. neoformans25253.126.2512.512.5
A. brasiliensis6.25250.783.126.2512.5
A. flavus6.2512.51.561.563.123.12
A. fumigatus12.5501.566.256.2525
* MIC means minimum inhibitory concentration (mg/mL).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shehabeldine, A.M.; Doghish, A.S.; El-Dakroury, W.A.; Hassanin, M.M.H.; Al-Askar, A.A.; AbdElgawad, H.; Hashem, A.H. Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion. Molecules 2023, 28, 5812. https://doi.org/10.3390/molecules28155812

AMA Style

Shehabeldine AM, Doghish AS, El-Dakroury WA, Hassanin MMH, Al-Askar AA, AbdElgawad H, Hashem AH. Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion. Molecules. 2023; 28(15):5812. https://doi.org/10.3390/molecules28155812

Chicago/Turabian Style

Shehabeldine, Amr M., Ahmed S. Doghish, Walaa A. El-Dakroury, Mahmoud M. H. Hassanin, Abdulaziz A. Al-Askar, Hamada AbdElgawad, and Amr H. Hashem. 2023. "Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion" Molecules 28, no. 15: 5812. https://doi.org/10.3390/molecules28155812

APA Style

Shehabeldine, A. M., Doghish, A. S., El-Dakroury, W. A., Hassanin, M. M. H., Al-Askar, A. A., AbdElgawad, H., & Hashem, A. H. (2023). Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion. Molecules, 28(15), 5812. https://doi.org/10.3390/molecules28155812

Article Metrics

Back to TopTop